A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis

NCT06491576 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH

Interventions

DRUG: BGT-002
DRUG: Placebo

Sponsor

Burgeon Therapeutics Co., Ltd.